Latest Opioid Stories
Additional Capital Enable Company to Achieve Additional Milestones in its Business Plan NEW YORK, Oct.
Data from Sublingual Sufentanil Development Program Highlights Onset of Analgesia, Safety and Effect of Gender on Analgesic Response REDWOOD CITY, Calif., Oct.
Butrans® is now available for prescribing in five dosage strengths STAMFORD, Conn., Oct. 9, 2014 /PRNewswire/ -- Purdue Pharma L.P. announced the U.S.
New white paper released as hydrocodone is reclassified as a Schedule II drug ITASCA, Ill., Oct.
REDWOOD CITY, Calif., Oct. 6, 2014 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc.
A new report from the CDC reveals that heroin deaths have risen sharply in many US states. However, despite this rise, twice as many people died from prescription opioid overdoses than heroin overdoses in these states in 2012.
LONDON, Oct. 2, 2014 /PRNewswire/ -- Lightlake Therapeutics Inc.
According to a new position statement from the American Academy of Neurology, the risk of death, overdose, addiction or serious side effects with prescription opioids outweigh the benefits in chronic, non-cancer conditions such as headache, fibromyalgia and chronic low back pain.
KemPharm's Intellectual Property Estate Now Includes Composition of Matter Patents for Two Ligand Activated Technology (LAT) Opioid Prodrugs - KP511 and KP201 CORALVILLE, Iowa, Sept.
DARIEN, Conn., Sept.
- A serpent whose bite was fabled to produce intense thirst.